Notice of AGM
Scancell Holdings PLC announced that its Annual Report and Accounts for the year ended April 30, 2025, along with the Notice of Annual General Meeting (AGM), will be sent to shareholders shortly. The annual report is available on the company's website at https://www.scancell.co.uk/investors/financial-info, and the Notice of AGM will be available today at https://scancell.co.uk/documents-presentations under the Annual General Meeting section. The AGM will be held on Thursday, October 30th, 2025, at 3:00 pm GMT at Cooley (UK) LLP in London, where the senior management team will present the final results for the year ended April 30, 2025, followed by a Q&A session.
Select text to share a quote on X · sign in to keep highlights & notes in your SCLP notes
Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope® active immunotherapies to treat cancer, announces that the Company's Annual Report and Accounts for the year ended 30 April 2025 and Notice of Annual General Meeting ("AGM") will be sent to shareholders shortly.
The Annual Report and Accounts for the year ended 30 April 2025 are available on the Company's website at https://www.scancell.co.uk/investors/financial-info, and the Notice of AGM will be made available today at https://scancell.co.uk/documents-presentations under the section titled Annual General Meeting.
The AGM will be held at 3.00pm GMT at the offices of Cooley (UK) LLP at 22 Bishopsgate, London, EC2N 4BQ on Thursday 30th October 2025.
After the AGM, Scancell's senior management team will be presenting the final results for the year ended 30 April 2025 followed by a Q&A session, and all shareholders are invited to attend in person.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.